IDEAYA Biosciences (IDYA) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free IDYA Stock Alerts $39.85 +0.83 (+2.13%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Studyprnewswire.com - April 24 at 10:05 AMIDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancerprnewswire.com - April 22 at 6:00 AMIDEAYA Biosciences (NASDAQ:IDYA) Trading Down 3.2%marketbeat.com - April 18 at 2:47 PMFederated Hermes Inc. Boosts Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - April 18 at 12:22 PMShort Interest in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Increases By 6.7%americanbankingnews.com - April 18 at 2:20 AMIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Short Interest Up 6.7% in Marchmarketbeat.com - April 16 at 7:41 AMIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Recommendation of "Buy" by Analystsmarketbeat.com - April 10 at 2:29 AMVanguard Group Inc. Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - April 6 at 4:15 AMIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - April 5 at 6:00 AMIDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Eventprnewswire.com - April 1 at 6:00 AMIDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $60.00 at Citigroupmarketbeat.com - March 21 at 12:40 PMValidea Detailed Fundamental Analysis - IDYAnasdaq.com - March 20 at 5:13 PMHudson Bay Capital Management LP Takes $944,000 Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - March 17 at 5:12 AMStrong Buy Rating for IDEAYA Biosciences Based on Strategic Partnership and Promising Oncology Pipelinemarkets.businessinsider.com - March 13 at 7:48 PMIdeaya gains after clinical trial pact with Merckmsn.com - March 12 at 2:04 PMIdeaya inks clinical trial pact with Merckseekingalpha.com - March 12 at 2:04 PMIDEAYA Biosciences (NASDAQ:IDYA) Trading Up 3.3%marketbeat.com - March 12 at 12:12 PMIDEAYA In Clinical Trial Deal With Merck To Evaluate IDE161 With KEYTRUDA In Endometrial Cancermarkets.businessinsider.com - March 12 at 8:07 AMIDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancerprnewswire.com - March 12 at 6:00 AMSchonfeld Strategic Advisors LLC Sells 35,489 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - March 11 at 5:40 AMIDEAYA Biosciences Stock (NASDAQ:IDYA), Quotes and News Summarybenzinga.com - March 10 at 6:07 AMTrexquant Investment LP Cuts Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - March 10 at 5:20 AMInvesco Ltd. Has $7.83 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - March 9 at 4:32 AMDemystifying IDEAYA Biosciences: Insights From 6 Analyst Reviewsmarkets.businessinsider.com - March 8 at 6:17 PMBTIG Research Initiates Coverage on IDEAYA Biosciences (NASDAQ:IDYA)marketbeat.com - March 8 at 8:38 AMAdage Capital Partners GP L.L.C. Sells 288,149 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - March 5 at 1:19 PMIDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Eventsprnewswire.com - March 4 at 6:00 AMEventide Asset Management LLC Makes New Investment in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - March 1 at 9:33 AMBoone Capital Management LLC Acquires 74,249 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)marketbeat.com - February 28 at 12:52 PMAnalysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Insulet (PODD)markets.businessinsider.com - February 26 at 5:32 AMIDEAYA Biosciences (IDYA) Price Target Increased by 28.90% to 51.57msn.com - February 24 at 10:38 AMIDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $57.00 at JPMorgan Chase & Co.marketbeat.com - February 23 at 1:44 PMIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Resultsfinance.yahoo.com - February 23 at 8:27 AMIDEAYA Biosciences, Inc. to Post FY2028 Earnings of $4.54 Per Share, Capital One Financial Forecasts (NASDAQ:IDYA)marketbeat.com - February 23 at 8:22 AMIDEAYA Biosciences (NASDAQ:IDYA) Rating Reiterated by Capital One Financialmarketbeat.com - February 23 at 6:35 AMIDEAYA Biosciences, Inc. (NASDAQ:IDYA) to Post FY2028 Earnings of $4.51 Per Share, Wedbush Forecastsmarketbeat.com - February 22 at 8:17 AMThe Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Expertsmarkets.businessinsider.com - February 21 at 2:27 PMRoyal Bank of Canada Raises IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $53.00marketbeat.com - February 21 at 10:25 AMIdeaya Biosciences price target raised by $10 at Oppenheimer, here's whyrealmoney.thestreet.com - February 20 at 8:00 PMRecap: IDEAYA Biosciences Q4 Earningsbenzinga.com - February 20 at 8:00 PMIDEAYA Biosciences Q4 Results Misses Estimatesmarkets.businessinsider.com - February 20 at 9:56 AMIDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updatefinance.yahoo.com - February 20 at 9:56 AMIDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updateprnewswire.com - February 20 at 6:00 AMIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Rating of "Buy" from Analystsmarketbeat.com - February 20 at 1:36 AMIdeaya Biosciences: A Strong Bet In Targeted Oncologyseekingalpha.com - February 16 at 3:24 PMIDYA Apr 2024 35.000 putfinance.yahoo.com - February 15 at 3:48 PMIDYA Apr 2024 45.000 putfinance.yahoo.com - February 15 at 10:48 AMIDYA Mar 2024 35.000 putfinance.yahoo.com - February 15 at 10:48 AMIDEAYA Biosciences (NASDAQ:IDYA) Reaches New 1-Year High at $47.24marketbeat.com - February 15 at 10:45 AMIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by Barclays PLCmarketbeat.com - February 15 at 4:43 AM Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 IDYA Media Mentions By Week IDYA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDYA News Sentiment▼0.360.43▲Average Medical News Sentiment IDYA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDYA Articles This Week▼63▲IDYA Articles Average Week Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arrowhead Pharmaceuticals News MoonLake Immunotherapeutics News ACADIA Pharmaceuticals News Crinetics Pharmaceuticals News Xenon Pharmaceuticals News MorphoSys News Evotec News Bausch Health Companies News Amicus Therapeutics News HUTCHMED News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDYA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
